Clinical trial
Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense…
NCT00330148 · Epicentre, Other · Terminated
Key facts
| NCT number | NCT00330148 |
|---|---|
| Title | Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis |
| Official title | Clinical Trial Comparing the Therapeutic Combinations Melarsoprol-Nifurtimox, Melarsoprol-Eflornithine and Eflornithine-Nifurtimox in the Treatment of Gambiense Human African Trypanosomiasis in the Meningo-Encephalitic Phase |
| Lead sponsor | Epicentre, Other |
| Collaborators | Médecins Sans Frontières, France Embassy of France in Uganda National Sleeping Sickness Control Program, Uganda |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Trypanosomiasis, African |
| Intervention type | Drug |
| Interventions | melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d, 10d + eflornithine 400 mg/kg/d, 7d, nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d |
| Enrollment | 435 |
| Start date | Mar 1, 2001 |
| Completion | Jun 1, 2004 |
| First posted | May 26, 2006 |
| Last update posted | May 26, 2006 |
| Countries | Uganda |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: